Skip to main content
FDA rejects teplizumab for type 1 diabetes delay
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA rejects teplizumab for type 1 diabetes delay
User login
Username
Password
Reset your password
Concept
Lead
score
Type 1 Diabetes Mellitus
1
1
Food and Drug Administration (FDA)
0
0.99
Pharmacokinetics
0
0.19
Clinical Research
0
0.1
Diabetes Research
0
0.1
Monoclonal Antibody
0
0.1
Biologic Therapy
0
0.08
Type 2 Diabetes Mellitus
0
0.08
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Cardiology
0
0.9
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.7
Pediatrics
0
0.6